tiprankstipranks
Advertisement
Advertisement

CareCloud Earnings Call Highlights Growth Amid Integration

CareCloud Earnings Call Highlights Growth Amid Integration

Carecloud, Inc. ((CCLD)) has held its Q1 earnings call. Read on for the main highlights of the call.

Claim 55% Off TipRanks

CareCloud’s latest earnings call painted a picture of solid momentum tempered by near-term growing pains. Management highlighted double-digit revenue growth, expanding recurring revenue and continued profitability, while acknowledging that integration and amortization costs from recent acquisitions are weighing on GAAP results and cash flow in the short term but should ease later in the year.

Revenue Growth

CareCloud reported Q1 2026 revenue of $31.3 million, up 13% from $27.6 million a year earlier. The performance underscores steady demand for the company’s health IT and revenue cycle services despite seasonal headwinds and softer project-based work.

Recurring Revenue Expansion

Recurring technology-enabled business solutions generated $23.0 million in Q1, rising by roughly $5.3 million year over year. This shift toward contracted, subscription-like revenue strengthens visibility and may support more predictable cash flows over time.

Profitability Streak Maintained

GAAP net income reached $922,000 in the quarter, marking CareCloud’s eighth straight period of positive GAAP earnings. The company is emphasizing consistent profitability even as it absorbs integration costs from its recent acquisitions.

Stable Adjusted Operating Performance

Adjusted EBITDA came in at $5.4 million, or 17% of revenue, with adjusted net income at $2.2 million, or $0.05 per share. These figures were essentially flat with the prior-year period, suggesting the core operating engine remains stable amid integration work.

Capital Structure Simplification

CareCloud closed a new $50 million credit facility, including a $40 million term loan and a $10 million revolver, and set up an at-the-market equity program for added flexibility. The board also moved to redeem all Series B preferred stock using approximately $41.6 million of prefunded capital, eliminating a long-standing overhang without diluting common shareholders.

Medsphere Integration and Market Expansion

The company continued integrating its 2025 Medsphere-related deals, which opened the door to the inpatient hospital market. With additions such as Wellsoft, CareView, ChartLogic, Marketware and new supply-chain and managed IT capabilities, CareCloud is broadening its addressable base and building cross-selling lanes.

Commercial AI Traction

StratusAI Desk Agent reached full commercial launch and is already handling about 75% of inbound calls for early adopter clients. Management said its AI Center of Excellence is accelerating both product innovation and internal efficiency, positioning AI as a key growth and margin lever.

GAAP Net Income Decline vs Prior Year

Despite remaining profitable, GAAP net income fell to $922,000 from $1.9 million in Q1 2025. The decline was driven largely by higher amortization of acquired intangibles and integration and transition costs tied to the Medsphere acquisition.

Free Cash Flow Decrease

Free cash flow slipped to $2.4 million from $3.6 million a year earlier, as integration-related cash outflows weighed on results. Management indicated these pressures should fade as integration milestones are completed and synergies begin to flow.

Slight Compression in Adjusted Results

Adjusted EBITDA edged down to $5.4 million from $5.6 million and adjusted net income dipped to $2.2 million from $2.3 million. The modest compression highlights near-term margin pressure while the company invests in integrating acquisitions and modernizing platforms.

Increased Amortization and Integration Costs

Higher amortization of acquired intangibles and transitional expenses from the 2025 deals materially affected GAAP profitability in Q1. Management cautioned that these effects will remain a headwind in the near term before tapering off, at which point they expect margins to expand.

Seasonality and Q1 Weakness

Executives reminded investors that Q1 is typically the weakest quarter due to deductible resets and other timing factors in healthcare billing. This built-in seasonality can compress revenue and margins, contributing to volatility when compared quarter to quarter.

Non-recurring Services Revenue Decline

Non-recurring project-based professional services revenue declined by about $2.9 million year over year, offsetting part of the gains elsewhere. The drop underscores CareCloud’s move toward stickier recurring revenue but also reduced top-line growth from services work in the quarter.

Liquidity and New Debt Obligations

As of March 31, CareCloud held about $3.9 million in cash and $2.6 million in net working capital, modestly better than at year-end. However, the preferred redemption refinancing shifts the burden from dividends to senior debt payments, with management flagging expected loan service of roughly $1.0–$1.1 million per month.

Medsphere Modernization and Technical Debt

Management noted that Medsphere’s platforms require significant modernization, including desktop-to-cloud migrations and tackling more than 50 carryforward items on the revenue cycle side. These upgrades are labor-intensive and will take time before full cross-sell and margin benefits are realized.

Guidance and Forward-Looking Outlook

CareCloud reaffirmed its 2026 outlook, calling for revenue between $128.0 million and $132.0 million, adjusted EBITDA of $29.0 million to $31.0 million and GAAP EPS of $0.20 to $0.23. If achieved, that would more than double 2025 EPS, with management counting on easing integration drag, stronger AI adoption and expanded hospital and health system penetration.

CareCloud’s earnings call underscored a company in transition but moving in the right direction, with recurring revenue and AI adoption rising while integration costs temporarily cloud the bottom line. For investors, the key questions will be how quickly modernization and cross-sell initiatives translate into stronger margins and whether the reaffirmed guidance holds as the year progresses.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1